Company profile
The Institute of Cancer Research, London
The Institute of Cancer Research, London, is one of the worlds most influential cancer research organisations, with an outstanding record of achievement.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Nov 2023 to 31 Oct 2024
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer, affecting around 20% of all people with breast cancer. It disproportionately affects younger women and ethnic minorities, and has profound effects on quality of life, fertility, and ability to work. There is overwhelming scientific evidence that TNBC is complex with diverse...
1 Apr 2008 to 31 Mar 2013
An Intra-Operative Dedicated Breast Magnetic Resonance (MR) Scanner for detection, diagnosis, image-guided lesion biopsy and targeted tissue ablation will be built, based on an existing, novel, proprietary MR scanner. Unlike the conventional, cylindrical MR scanners which do not provide for real-time , interactive guidance of biopsy and therapy devices - ...
1 Nov 2007 to 31 Dec 2010
Awaiting Public Summary
1 Apr 2006 to 30 Sep 2007
Preliminary clinical images from PETRRA''s prototype whole-body PET camera have shown that this novel technology could provide the basis of a high quality, high speed system for mainstream clinical applications at a cost substantially lower than existing PET systems. This proposal addresses the research and development needed to prove that the existing ba...
